Engineered AAVs for Safe & Therapeutic Delivery to CNS, Muscle, & Eye

• Our shared challenge: therapeutic, broadly applicable, and safe gene delivery
• Leveraging the power of pooled in vivo screens and AI-guided sequence design
• Next-generation AAV capsids for CNS, muscle, and ophthalmic therapeutics

Speakers:

Adrian Veres

Chief Scientific Officer & Co-Founder

Dyno Therapeutics